Case of the Week
Section Editors: Matylda Machnowska1 and Anvita Pauranik2
1University of Toronto, Toronto, Ontario, Canada
2BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Sign up here to receive an email alert when a new Case of the Week is posted.
June 27, 2019
ANTI-NMDA RECEPTOR ENCEPHALITIS
- Background
- N-methyl D-aspartate receptor (NMDA receptor or NMDA-R) encephalitis is one of the most common and best characterized subtypes of Autoimmune Encephalitis.
- The NMDA-R is a glutamate receptor and ion channel protein found in nerve cells.
- This subtype is mediated by IgG antibodies against the Glutamate N1 subunit of the neuronal NMDA receptors.
- NMDA-R encephalitis is associated with an underlying ovarian teratoma and ovarian carcinoma in 45% and 23% of women, respectively.
- Clinical Presentation
- Presentation is sub acute to chronic over the span of weeks to months.
- Clinical features are characterized by an initial viral-like prodrome, followed by psychiatric symptoms that includes anxiety, depression, schizophrenia, and psychosis.
- Further progression includes temporal lobe dysfunction (amnesia and seizures) and ultimately culminate in severe neurologic deficits, including autonomic dysfunction, dystonia/dyskinesia, and profound encephalopathy.
- Key Diagnostic Features
- MRI can be normal on initial presentation in about 66%-89% of cases, as opposed to other autoimmune encephalitis.
- Lesions in the hippocampus are the most common abnormal MR imaging finding observed.
- Abnormal FLAIR or T2 hyperintense signals can be seen in the medial temporal lobe, cerebral cortex, basal ganglia, thalamus, and brainstem with or without hippocampal lesions.
- On FDG-PET imaging, hyper-metabolism is seen in mesial temporal lobe structures .
- On ASL perfusion imaging, diffuse increased cerebral blood flow is seen, but is nonspecific for autoimmune encephalitis.
- Differential Diagnosis
- Anti-Hu encephalitis (or other intracellular antigents): Classically paraneoplastic and whole body PET can show primary lesions elsewhere.
- LG1/CASPR2 (former VGKC) encephalitis: Typically presents with dystonia, myotonia, and cognitive decline, among other complaints.
- Systemic Autoimmunity with Encephalopathy: Includes antiphospholipid antibodies and anti-glutamate receptor antibodies.
- Viral encephalitis/syphilitic encephalitis: Will vary depending on the agent and the host immune status, and the diagnosis will be made by PCR or serology.
- Treatment
- Initial treatment is with high-dose steroids and either IVIG(400 mg/kg per day for five days) or plasma exchange in most patients, in addition to tumor removal when appropriate.
- Rituximab and cyclophosphamide are the second-line agents used. Associated with higher percentage of successful outcomes and decreased relapse occurrence.